Diabetes Kongress 2023
zur Liste
Prof. Dr. Matthias von Herrath
Matthias von Herrath, M.D. Vice President, and Senior Medical Officer, Global Chief Medical Office Novonordisk Professor at the La Jolla Institute 1988 – MD from the University of Freiburg, Germany 1988-1991 – Residency in Internal and emergency medicine 1991-1995 – Postdoctoral DFG and JDRF fellowships at Scripps with Michael Oldstone – Immunology and Virology 1995-1999 – Assistant Professor at Scripps – Viral autoimmunity 1999-2001 – Associate Professor at Scripps 2001-2005 – Associate Professor with Tenure – La Jolla Institute 2005 – present - Professor and Director, Type 1 Research Center at La Jolla Institute 2008 – ADA Outstanding Scientific Achievement Award 2012 – Vice President and Head NovoNordisk Type 1 diabetes Research Center Seattle 2014 and 2018 – Ranked as Type 1 leading investigator by Expertscape at ADA 2014 – Paul Langerhans Medal from German Diabetes Sociaty (DDG) 2017- 2018 – Vice President for Type 1 Diabetes and Kidney Disease NNRCS Seattle 2018 – present Vice president and Senior Medical Officer, Global Chief Medical Office, Novonordisk – section type 1 diabetes and stem cells with focus on complications 2019 - Standing member of NIH HAI study section 2016 – present - Member of the Germen Excellence Initiative review committee
Novo Nordisk Pharma GmbH United States
  • Session Immunintervention zur Vorbeugung und Therapie des Typ-1-Diabetes Vorsitz
    Datum: 19.05.2023 , Zeit: 16:00 | Thema: Typ-1-Diabetes
    Details
  • Vortrag DNA Vaccination Speaker
    Datum: 19.05.2023 , Zeit: 16:10 | Thema: Typ-1-Diabetes
    Details